Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Radeberg

11 clinical trials in Radeberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Radeberg at a glance
11
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Radeberg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Longboard Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Carisbamate
  • Sponsor:Sk Life Science Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Longboard Pharmaceuticals Inc.

Partial seizures

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Soticlestat
  • Sponsor:Takeda Development Center Americas Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cenobamate
  • Sponsor:Sk Life Science Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Radeberg

What the registry says about research in the country

01 Focal Epilepsy Research

Innovative studies focusing on focal-onset seizures and their treatment, evaluating new therapeutic approaches for patients with refractory conditions.

  • XEN1101 Clinical Evaluation
  • BHV-7000 Safety Studies
  • Refractory Cases Management

Multiple trials are examining long-term safety profiles and efficacy of novel anticonvulsant medications.

02 Generalized Seizure Studies

Research targeting primary generalized tonic-clonic seizures, including investigations of cenobamate and other emerging therapies.

  • Cenobamate Safety Assessment
  • Idiopathic Generalized Epilepsy
  • Novel Drug Development

Studies are focused on reducing seizure frequency and improving patient outcomes.

03 Rare Epilepsy Syndromes

Comprehensive research into rare conditions including Lennox-Gastaut syndrome and Dravet syndrome, evaluating innovative treatment approaches.

  • Soticlestat Clinical Trials
  • Caribasmate Efficacy Studies
  • Tuberous Sclerosis Complex Research

Trials aim to develop targeted therapies for these challenging neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.